Purple Biotech (PPBT) Other Operating Expenses (2017 - 2021)

Purple Biotech (PPBT) has 4 years of Other Operating Expenses data on file, last reported at $154000.0 in Q3 2021.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $154000.0 in Q3 2021; TTM through Jun 2022 was $154000.0, a 13.24% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 14487.86% from the prior year.
• Other Operating Expenses for Q3 2021 stood at $154000.0, up from $136000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for PPBT reached as high as $3.9 million in Q4 2017 and fell as low as -$166000.0 in Q4 2019.
• Historically, Other Operating Expenses has averaged $793800.0 across 4 years, with a median of $136000.0 in 2021.
• Across the five-year window, Other Operating Expenses slumped 100.72% in 2018 and plunged 492.86% in 2019, its largest moves.
• Year by year, Other Operating Expenses stood at $3.9 million in 2017, then sank by 100.72% to -$28000.0 in 2018, then plunged by 492.86% to -$166000.0 in 2019, then soared by 192.77% to $154000.0 in 2021.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $154000.0 in Q3 2021, $136000.0 in Q1 2021, and -$166000.0 in Q4 2019.